Skip to content

Effect of different doses of dexmedetomidine hydrochloride on postoperative hypotension and delusion in elderly patients with resection of prostate

Effect of different doses of dexmedetomidine hydrochloride on postoperative hypotension and delusion in elderly patients with resection of prostate

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400080509
Enrollment
Unknown
Registered
2024-01-31
Start date
2024-02-15
Completion date
Unknown
Last updated
2024-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperplasia prostate

Interventions

Normal Saline group (NS group):Normal Saline group (NS group) received 50 m L/h of normal saline, a continuous infusion for 10 min, and a maintenance dose of 10 mL / h.
Low-dose dexmedetomidine group (Group D1):Low-dose dexmedetomidine group (Group D1): Dexmedetomidine 0.4 ug / kg loading dose, 0.2 ugkg-1 h-1 maintenance dose
Medium Dose dexmedetomidine group (group D2): Medium Dose dexmedetomidine group (group D2): Dexmedetomidine 0.4 ug / kg loading dose, 0.4 ugkg-1 h-1 maintenance dose
High Dose dexmedetomidine group (group D3):High Dose dexmedetomidine group (group D3): Dexmedetomidine 0.4 ug / kg loading dose, 0.6 ugkg-1 h-1 maintenance dose

Sponsors

Ya 'an People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
65 Years to 100 Years

Inclusion criteria

Inclusion criteria: ? Age = 65 years; ? ASA grade?-?; ? elective electrosurgical prostate; ? body mass index (BMI): 18-24kg / m2;

Exclusion criteria

Exclusion criteria: ? patients and family members refused; ? ASA grade ?-?; ? heart failure, severe arrhythmia, severe bradycardia (HR below 40 beats / min), atrioventricular block above degree II and morbid sinus syndrome; ? severe hepatic and renal dysfunction.

Design outcomes

Primary

MeasureTime frame
mean arterial pressure;postoperative delirium;

Secondary

MeasureTime frame
Heart rate ;Number of intraoperative cardiovascular medications administered;Duration of awakening period;peri-arousal mania;Remedial analgesia;postoperative nausea and vomiting;

Countries

China

Contacts

Public ContactZhou Shuzhi

Ya 'an People's Hospital

zszch@sina.com+86 182 8356 0691

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026